Zobrazeno 1 - 10
of 220
pro vyhledávání: '"mohammad hojjat"'
Autor:
Mohammad Sadeghi, Asma Moslehi, Hadiseh Kheiry, Fariba Karoon Kiani, Asieh Zarei, Atefeh Khodakarami, Vahid Karpisheh, Ali Masjedi, Badrossadat Rahnama, Mohammad Hojjat-Farsangi, Mortaza Raeisi, Mehdi Yousefi, Ali Akbar Movasaghpour Akbari, Farhad Jadidi-Niaragh
Publikováno v:
Cancer Cell International, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background Acute myeloid leukemia (AML), a malignancy Often resistant to common chemotherapy regimens (Cytarabine (Ara-c) + Daunorubicin (DNR)), is accompanied by frequent relapses. Many factors are involved in causing chemoresistance. Heme
Externí odkaz:
https://doaj.org/article/bef54dacc09d4d8ba2dd2c68b4fcd773
Autor:
Asal Barshidi, Keivan Ardeshiri, Farbod Ebrahimi, Fatemeh Alian, Ali Akbar Shekarchi, Mohammad Hojjat-Farsangi, Farhad Jadidi-Niaragh
Publikováno v:
Cell Communication and Signaling, Vol 22, Iss 1, Pp 1-13 (2024)
Abstract The immune responses to cancer cells involve both innate and acquired immune cells. In the meantime, the most attention has been drawn to the adaptive immune cells, especially T cells, while, it is now well known that the innate immune cells
Externí odkaz:
https://doaj.org/article/00fa12b0f3804abf8c75e0fdd83fd2d5
Autor:
Atefeh Khodakarami, Mahsa Afsari Kashani, Atefeh Nazer, Armin Mahmoudsalehi Kheshti, Bentolhoda Rashidi, Vahid Karpisheh, Ali Masjedi, Shiva Abolhasani, Sepideh Izadi, Rafieh Bagherifar, Seyyed Sina Hejazian, Hamed Mohammadi, AliAkbar Movassaghpour, Abbas Ali Hosseinpour Feizi, Mohammad Hojjat-Farsangi, Farhad Jadidi-Niaragh
Publikováno v:
Cell Communication and Signaling, Vol 21, Iss 1, Pp 1-16 (2023)
Abstract Background Targeting influential factors in resistance to chemotherapy is one way to increase the effectiveness of chemotherapeutics. The nuclear factor erythroid 2-related factor 2 (Nrf2) pathway overexpresses in chronic lymphocytic leukemi
Externí odkaz:
https://doaj.org/article/84bb4d6d12e846eaad43995f13b52c41
Autor:
Mohammad Sadeghi, Mehrdad Fathi, Jamshid Gholizadeh Navashenaq, Hamed Mohammadi, Mehdi Yousefi, Mohammad Hojjat-Farsangi, Afshin Namdar, Ali Akbar Movasaghpour Akbari, Farhad Jadidi-Niaragh
Publikováno v:
Cell Communication and Signaling, Vol 21, Iss 1, Pp 1-21 (2023)
Abstract Background Heme oxygenase-1 (HO-1), a heme-degrading enzyme, is proven to have anti-apoptotic effects in several malignancies. In addition, HO-1 is reported to cause chemoresistance and increase cell survival. Growing evidence indicates that
Externí odkaz:
https://doaj.org/article/39d9b7e47e3c4c21b66b7015a913854c
Autor:
Atefeh Khodakarami, Sara Adibfar, Vahid Karpisheh, Shiva Abolhasani, Pooya Jalali, Hamed Mohammadi, Jamshid Gholizadeh Navashenaq, Mohammad Hojjat-Farsangi, Farhad Jadidi-Niaragh
Publikováno v:
Cancer Cell International, Vol 22, Iss 1, Pp 1-24 (2022)
Abstract NF-E2-related factor 2 (Nrf2) transcription factor has contradictory roles in cancer, which can act as a tumor suppressor or a proto-oncogene in different cell conditions (depending on the cell type and the conditions of the cell environment
Externí odkaz:
https://doaj.org/article/177acf0e7a5945f89c01c7ccb2c72e75
Publikováno v:
مجله مطالعات ایرانی, Vol 21, Iss 41, Pp 1-29 (2022)
Introduction Study on people’s daily life, aiming at understanding both science and art used by them, is among the most extensive categories of research world. Exactly it is during such studies that most uncertainties are resolved and new theories
Externí odkaz:
https://doaj.org/article/effb27392cf841ca943ac463149fb742
Autor:
Ramin Pourakbari, Mehdi Yousefi, Balal Khalilzadeh, Mahsa Haddad Irani-nezhad, Alireza Khataee, Leili Aghebati-Maleki, Alireza Soleimanian, Amin Kamrani, Forough Chakari-Khiavi, Rozita Abolhasan, Morteza Motallebnezhad, Farhad Jadidi-Niaragh, Bahman Yousefi, Hossein Samadi Kafil, Mohammad Hojjat-Farsangi, Mohammad-Reza Rashidi
Publikováno v:
Cancer Nanotechnology, Vol 13, Iss 1, Pp 1-17 (2022)
Abstract Background Recently, biosensors have become popular analytical tools for small analytes due to their high sensitivity and wide analytical range. In the present work, development of a novel biosensing method based on tungsten disulfide quantu
Externí odkaz:
https://doaj.org/article/80f8810b40394f37a5b9540428d97a96
Autor:
Amineh Ghaderi, Mohammad‐Ali Okhovat, Layung Sekar Sih Wikanthi, Ann Svensson, Marzia Palma, Johan Schultz, Thomas Olin, Anders Österborg, Håkan Mellstedt, Mohammad Hojjat‐Farsangi
Publikováno v:
eJHaem, Vol 2, Iss 3, Pp 498-502 (2021)
Abstract ROR1 – a receptor tyrosine kinase – is overexpressed in CLL. Ibrutinib, a Bruton's tyrosine kinase inhibitor, is clinically effective in CLL but patients may develop resistance. We evaluated the effect of an ROR1 inhibitor, KAN0441571C,
Externí odkaz:
https://doaj.org/article/0aa8be017263486cb8f895e3be923506
Autor:
Walter Z. Wang, Konstantin Shilo, Joseph M. Amann, Alyssa Shulman, Mohammad Hojjat-Farsangi, Håkan Mellstedt, Johan Schultz, Carlo M. Croce, David P. Carbone
Publikováno v:
Cell Death and Disease, Vol 12, Iss 6, Pp 1-9 (2021)
Abstract Small cell lung cancer (SCLC) remains a deadly form of cancer, with a 5-year survival rate of less than 10 percent, necessitating novel therapies. Receptor tyrosine kinase-like orphan receptor 1 (ROR1) is an oncofetal protein that is emergin
Externí odkaz:
https://doaj.org/article/8e3d803832bd442687414f1eec0b50ef
Autor:
Amineh Ghaderi, Mohammad-Ali Okhovat, Jemina Lehto, Luigi De Petris, Ehsan Manouchehri Doulabi, Parviz Kokhaei, Wen Zhong, Georgios Z. Rassidakis, Elias Drakos, Ali Moshfegh, Johan Schultz, Thomas Olin, Anders Österborg, Håkan Mellstedt, Mohammad Hojjat-Farsangi
Publikováno v:
Pharmaceutics, Vol 15, Iss 4, p 1148 (2023)
The ROR1 receptor tyrosine kinase is expressed in embryonic tissues but is absent in normal adult tissues. ROR1 is of importance in oncogenesis and is overexpressed in several cancers, such as NSCLC. In this study, we evaluated ROR1 expression in NSC
Externí odkaz:
https://doaj.org/article/1287c54575b8479d88d0bd97b869a154